'Bionic Pancreas' Approved by FDA

A closed-loop insulin delivery system, combining a continuous glucose monitoring device with an insulin pump, was approved for U.S. marketing Wednesday, the FDA announced.

"This first-of-its-kind technology can provide people with type 1 diabetes greater freedom to live their lives without having to consistently and manually monitor baseline glucose levels and administer insulin," said Jeffrey Shuren, MD, JD, director of the FDA's Center for Devices and Radiological Health, in a statement announcing the decision.